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Edited by Ned ManteiAbstract In this study, we investigated the mechanisms of
kahweol protection of neuronal cells from cell death induced
by the Parkinsons disease-related neurotoxin 6-hydroxydop-
amine (6-OHDA). Pretreatment of SH-SY5Y cells with
kahweol signiﬁcantly reduced 6-OHDA-induced generation of
ROS, caspase-3 activation, and subsequent cell death. Kahweol
also up-regulated heme oxygenase-1 (HO-1) expression, which
conferred neuroprotection against 6-OHDA-induced oxidative
injury. Moreover, kahweol induced PI3K and p38 activation,
which are involved in the induction of Nrf2, HO-1 expression,
and neuroprotection. These results suggest that regulation of
the anti-oxidant enzyme HO-1 via the PI3K and p38/Nrf2
signaling pathways controls the intracellular levels of ROS.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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High levels of reactive oxygen species (ROS) induce cell
death in the nervous system and have been associated with a
number of pathologies such as Parkinsons disease (PD) [1].
Mammalian cells have developed several protective mecha-
nisms to prevent ROS formation or to detoxify ROS. These
mechanisms involve both anti-oxidants and protective en-
zymes [2]. Among the various cytoprotective enzymes, the pro-
tective functions of heme oxygenase-1 (HO-1) have recently
been emphasized [3]. HO-1 is a novel enzyme with potent
anti-inﬂammatory [4], anti-oxidant [5], and anti-proliferative
eﬀects [6]. The HO-1 gene is primarily regulated at the tran-
scriptional level, and its inducibility is linked to the transcrip-
tion factor NF-E2-related factor 2 (Nrf2) [7]. Under normal
conditions, Nrf2 is sequestered in the cytoplasm by binding
to Keap1, an actin-binding protein [8]. Recent studies suggest
that Nrf2 nuclear translocation requires the activation of sev-
eral signal transduction pathways, such as mitogen-activated
protein kinases (MAPKs) [9], protein kinase C (PKC) [10],
and phosphatidylinositol 3-kinase (PI3K) [11]. As increasing*Corresponding author. Fax: +82 62 230 6639.
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doi:10.1016/j.febslet.2008.06.045evidence indicates that HO-1 provides protection, modulation
of HO-1 expression may represent a novel target for therapeu-
tic intervention. In particular, a non-cytotoxic pharmacologi-
cal inducer of HO-1 may maximize the intrinsic anti-oxidant
potential of cells.
Coﬀee is a complex chemical mixture composed of several
chemicals. It exerts a number of bioactivities and numerous
compounds are responsible for these eﬀects. The signiﬁcant,
documented bioactivities include anti-oxidant activity
[12,13], anti-carcinogenic activity [14], anti-mutagenic activity
[15], etc. We recently reported that kahweol and cafestol have
anti-oxidant eﬀects [16]. While these studies suggest that the
anti-oxidative potential of kahweol is responsible for at least
some of these eﬀects, there is no unequivocal proof for this
assumption. Also, whether kahweol can prevent or alleviate
brain injury induced by 6-OHDA and the mechanisms by
which kahweol protects against 6-OHDA-induced neurotox-
icity remains unclear. In this study, we demonstrate that kah-
weol-induced activation of PI3K/Akt and p38 up-regulates the
expression and activity of HO-1, which, in turn, protects
against 6-OHDA-induced oxidative damage in SH-SY5Y
cells.2. Materials and methods
2.1. Materials
Reagents used in this study were purchased from the following
sources; kahweol, 6-OHDA, and zinc protoporphyrin (ZnPP) from
Sigma (St. Louis, MO); MTT-based colorimetric assay kit from
Roche (Indianapolis, IN); 2,7-dichloroﬂuorescein diacetate
(H2DCFDA) from Molecular Probes (Eugene, OR); antibodies
for phospho-Akt, phospho-p38 MAPK, and HRP-conjugated
anti-rabbit IgG from Cell Signaling Technology (Beverly, MA);
antibodies for b-actin, Nrf2 and HO-1 from Calbiochem (La Jolla,
CA). The HO-1-ARE-luciferase reporter gene was kindly provided
by Dr. J. Alam (Tulane University School of Medicine, New Or-
leans, LA). All other chemicals were of the highest grade commer-
cially available.2.2. Cell culture and cell viability assay
Human neuroblastoma SH-SY5Y cells were obtained from the
American Type Culture Collection (ATCC, Rockville, MD) and
grown in Dulbeccos modiﬁed Eagles medium supplemented with
10% heat-inactivated fetal bovine serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 mg/ml streptomycin at 37 C in an
atmosphere of 5% CO2. Kahweol was dissolved in dimethylsulfoxide
(DMSO) and the stock solutions were added directly to the culture
media. The control cells were treated with DMSO only. The ﬁnalblished by Elsevier B.V. All rights reserved.
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Fig. 1. Kahweol prevents 6-OHDA-induced cell death. SH-SY5Y cells were treated with kahweol (1, 5 and 10 lM) for 12 h then incubated with 6-
OHDA (50 or 100 lM) for a further 24 h. (A) Cell viability was measured by MTT assays. *, #Signiﬁcantly diﬀerent from 6-OHDA-treated cells. (B)
TUNEL assays were performed according to the manufacturers instruction. (C) The catalytic activities of caspase-3 and -9 in cell lysates were
assayed using the speciﬁc substrates DEVD-pNA and LEHD-pNA. *, #Signiﬁcantly diﬀerent from 6-OHDA-treated cells.
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Y.P. Hwang, H.G. Jeong / FEBS Letters 582 (2008) 2655–2662 2657concentration of solvent was always <0.1%. Cell viability was exam-
ined using MTT-based assays according to the manufacturers
instructions.
2.3. ROS production
ROS production in SH-SY5Y cells was measured using the redox-
sensitive ﬂuorescent dye H2DCFDA. After treatment with 50 lM 6-
OHDA or vehicle for 6 h, cells were incubated with 25 lMH2DCFDA
for 20 min. The cells were rinsed twice with phenol-red-free DMEM
containing 1% FBS, and ﬂuorescence was detected on a ﬂuorescence
reader (Varioskan, Thermo Electon Co.) by measuring the emission
at 530 nm after excitation at 485 nm.16A2.4. Electrophoretic mobility shift assay
Synthetic double-stranded oligonucleotide containing the Nrf2-
binding domain (ARE) was labeled with [c-32P]-ATP using T4
polynucleotide kinase and separated from unincorporated [c-32P]-
ATP by gel ﬁltration on a nick spin column. Prior to addition
of the [c-32P]-labeled oligonucleotide, 10 lg of nuclear extract
was incubated on ice for 15 min in gel shift-binding buﬀer [20%
glycerol, 5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250 mM
NaCl, and 50 mM Tris–HCl, pH 7.5, with 0.25 lg/ml poly(dI-
dC)]. DNA–protein complexes were resolved by 6% polyacryl-
amide gel electrophoresis at 150 V for 2 h and visualized by auto-
radiography.6
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l)2.5. Transient transfection and luciferase assay
Cells (3 · 105 cells/well) were replated in 12-well plates overnight and
transiently co-transfected with HO-1-ARE-promoter-luciferase con-
struct and pRL-SV plasmid (Renilla luciferase expression for normal-
ization) (Promega, Madison, WI) using LipofectAMINE 2000
reagent (Invitrogen, Carlsbad, CA). Relative luciferase activities were
calculated by normalizing HO-1-ARE-promoter-driven ﬁreﬂy lucifer-
ase activity to Renilla luciferase activity.0
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B2.6. HO-1 assay
HO enzyme activity was measured as previously described [17].
2.7. Immunocytochemistry
Cells grown on poly-L-lysine-coated coverslips were treated with
kahweol for 3 h; the cells were then washed with PBS and ﬁxed
with 2% (w/v) paraformaldehyde. After permeabilization, the cov-
erslips were blocked with 1% BSA and then incubated with rabbit
anti-Nrf2 polyclonal antibody for 1 h. The sections were then
incubated with the secondary antibody, Alexa Fluor 488-conju-
gated donkey anti-rabbit antibody (Molecular Probes, OR), for
30 min. After two further washes in PBS, the cells were counter-
stained with 1 lg/ml of DAPI for 5 min. The coverslips were then
mounted with mounting medium (Dako, Hamburg, Germany) and
analyzed by ﬂuorescence microscopy (Axiovert 200M, Carl Zeiss,
Germany).0
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Kahweol treatment (hr)2.8. Reverse transcriptase-polymerase chain reaction
Total RNA was isolated from cells using Trizol (GibcoBRL,
Grand Island, NY). Reverse transcriptase-polymerase chain reaction
(RT-PCR) was performed by standard techniques. The PCR condi-
tions for HO-1 and for the housekeeping gene, GAPDH, were as fol-
lows: 25 cycles of 94 C for 30 s; 56 C for 30 s; and 72 C for 45 s.
Ampliﬁed products were resolved by 1.5% agarose gel electrophore-
sis, stained with ethidium bromide, and photographed under ultravi-
olet light.Fig. 2. Eﬀects of kahweol on 6-OHDA-induced cellular ROS produc-
tion. (A) Cells were pretreated with kahweol (1–10 lM) or vehicle for
12 h. After the medium was removed, SH-SY5Y cells were exposed to
6-OHDA (50 lM) for 6 h and ﬂuorescence was then measured using
FL600 ﬂuorescence spectrophotometer. *Signiﬁcantly diﬀerent from 6-
OHDA-treated cells. (B) Prevention of 6-OHDA-induced ROS by
kahweol depends on the duration of kahweol pretreatment. *Signif-
icantly diﬀerent from untreated cells.2.9. Western immunoblot analysis
Western blotting was performed using anti-HO-1, anti-phospho-
Akt, anti-phospho-p38, and anti-b-actin antibodies. Protein samples
were heated at 95 C for 5 min and analyzed by SDS–PAGE. Immuno-
blot signals were developed by enhanced chemiluminescence (Pierce
Biotechnology, Rockford, IL).2.10. Determination of caspase-3 and -9 activities
A modiﬁcation of the method described by Wang et al. was used to
examine caspase activation [18]. Cells treated with the indicated com-
binations of kahweol and 6-OHDA were lysed in hypotonic buﬀer
[20 mM Tris–HCl (pH 7.5), 1 mM EDTA, 100 lM PMSF, 2 lg/ml
each of aprotinin, pepstatin, and leupeptin]. The supernatants were
collected and incubated with 100 lM DEVD-pNA or LEHD-pNA
as a substrate at 37 C. The change in absorbance was measured at
405 nm using a plate reader.
2.11. TUNEL assay
Apoptosis was detected by terminal deoxynucleotidyltransferase-
mediated dUTP-biotin nick-end labeling (TUNEL) analysis using the
DeadEnd Fluorometric TUNEL System (Promega).
2.12. Statistical analysis
All experiments were repeated at least three times. Means ± S.D.
were calculated for each group and Dunnetts t-test was used to calcu-
late statistical signiﬁcance. Diﬀerences were considered statistically sig-
niﬁcant when P < 0.01.
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Fig. 3. Eﬀect of kahweol on HO-1 mRNA, protein expression and enzyme activity. (A) Cells were exposed to various concentrations of kahweol for
12 h and total RNA was extracted. HO-1 mRNA and protein expression were analyzed by RT-PCR and Western blotting. (B) Cells were exposed to
10 lM kahweol for 12 h and total RNA and protein were extracted at the times indicated. HO-1 mRNA and protein expression were analyzed by
RT-PCR and Western blotting. (C) HO-1 activity was measured 12 h after exposure to various concentrations of kahweol. *Signiﬁcantly diﬀerent
from untreated cells. (D) SH-SY5Y cells were untreated or pretreated with 50 lM cycloheximide or 10 lg/ml actinomycin D for 2 h prior to the
addition of 10 lM kahweol for an additional 12 h.
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3.1. Kahweol protects against 6-OHDA-induced neuronal cell
death
The protective eﬀect of kahweol against 6-OHDA-induced
oxidative stress in SH-SY5Y cells was assessed. Kahweol treat-
ment dose-dependently increased cell survival following 6-
OHDA treatment (Fig. 1A). The protective eﬀects of kahweol
against 6-OHDA-induced apoptosis were determined using
TUNEL assays. TUNEL staining was increased by treatment
of SH-SY5Y cells with 6-OHDA for 24 h, whereas kahweol
signiﬁcantly reduced 6-OHDA-induced TUNEL staining
(Fig. 1B). Caspase-3 plays a pivotal role in the terminal execu-
tion phase of apoptosis induced by diverse stimuli. To examine
whether kahweol prevented caspase-3 activity, DEVDase
activity was determined to measure caspase-3 activation. Kah-
weol pre-treatment signiﬁcantly reduced the level of 6-OHDA-
induced DEVDase activity (Fig. 1C); kahweol had similar ef-fects on 6-OHDA-induced caspase-9 activity as determined
by measuring its activation with a caspase-9-speciﬁc LEHD-
pNA substrate (Fig. 1C). These results suggest that kahweol
inhibits 6-OHDA-induced apoptosis and necrosis in SH-
SY5Y cells.3.2. Kahweol reduces 6-OHDA-induced ROS generation
We determined the eﬀect of kahweol on 6-OHDA-induced
ROS generation in SH-SY5Y cells. Pretreatment with kahweol
signiﬁcantly reduced the 6-OHDA-induced ROS generation,
indicating that kahweol attenuates ROS production (Fig.
2A). Moreover, this eﬀect was dependent on the duration of
kahweol pretreatment, that is, attenuation of ROS release by
kahweol required at least 3-h pretreatment with kahweol prior
to the addition of 6-OHDA (Fig. 2B). These results suggest
that kahweol induces the expression of a gene(s) essential to
ROS antagonism.
Y.P. Hwang, H.G. Jeong / FEBS Letters 582 (2008) 2655–2662 26593.3. Kahweol up-regulates HO-1 expression
As HO-1 is an important component of the cellular defense
against oxidative stress, we next assessed whether kahweol
could induce HO-1 expression. Cells were treated with kahweol
for 12 h, and kahweol treatment dose-dependently increased
HO-1 mRNA and protein expression and enzyme activity
(Fig. 3A and C). Treatment with kahweol (10 lM) also resulted
in time-dependent increases in HO-1 mRNA and protein
expression (Fig. 3B). The enhanced HO-1 expression correlated
with increased HO-1 activity. This increase was sensitive to pre-
treatment with actinomycinDor cycloheximide, suggesting that
kahweol enhances the expression of the inducible heme oxygen-
ase isoform, HO-1. Moreover, the increase in mRNA was also
sensitive to cycloheximide, suggesting that induction of HO-1
transcription involves de novo protein synthesis (Fig. 3D).
3.4. Kahweol induces Nrf2 nuclear translocation
Most of the genes encoding phase II detoxifying and anti-oxi-
dant enzymes contain an ARE sequence in their promoter re-
gion. Nrf2 is an important transcription factor that regulatesA
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the HO-1-ARE reporter plasmid and treated with kahweol (1–10 lM). After
diﬀerent from untreated cells.ARE-driven HO-1 gene expression. We therefore examined
whether kahweol activated Nrf2 in association with its upregu-
lation of HO-1 in SH-SY5Y cells. Kahweol treatment increased
Nrf2 accumulation in the nucleus (Fig. 4A and B). Nrf2 activa-
tion in kahweol-treated cells was assessed by EMSA with an
oligonucleotide harboring a consensus Nrf2 binding element.
Kahweol-treated cells exhibited high levels of Nrf2 binding
(Fig. 4C). Also, kahweol increased the transcriptional activity
of Nrf2 (Fig. 4D). These results suggest that induction of
HO-1 by kahweol involves Nrf2-mediated ARE activation.
3.5. Involvement of PI3K/MAPK pathway in HO-1 expression
by kahweol
Many studies have demonstrated that several MAPKs,
including JNK, p38, ERK and PI3K, are involved in regulat-
ing the phosphorylation of Nrf2 and ARE-mediated phase II
gene expression [19]. To further explore the upstream signaling
pathway involved in kahweol-mediated Nrf2 activation and
induction of HO-1, the activation of PI3K/Akt and MAPKs
was examined in SH-SY5Y cells. Interestingly, PI3K/AktNrf2-FITC DAPI Merge
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incubated with 10 lM LY294002 or 20 lM SB203580 for 30 min and then incubated with 10 lM kahweol for 12 h. Whole cell lysates were subjected
to Western blotting analysis with anti-HO-1 and anti-b-actin antibodies. (C) Eﬀect of PI3K and p38 inhibitors on kahweol-induced Nrf2
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cell lysates were mixed with luciferase substrate. The luciferase activity was measured by luminometer. *Signiﬁcantly diﬀerent from kahweol-treated
cells. (E) SH-SY5Y cells were treated with 10 lM kahweol in the absence or presence of LY294002 or SB203580 for 3 h, and then immunostained to
detect the nuclear localization of Nrf2.
2660 Y.P. Hwang, H.G. Jeong / FEBS Letters 582 (2008) 2655–2662and p38 were phosphorylated by kahweol (Fig. 5A). Further-
more, HO-1 expression and nuclear accumulation of Nrf2 were
reduced by LY294002 (PI3K inhibitor) and SB203580 (p38
inhibitor) (Fig. 5B, C and E). Likewise, HO-1 transcription
was eﬀectively blocked by LY294002 and SB203580 (Fig.
5D). These results indicate a role for PI3K and p38 signaling
in kahweol-mediated HO-1 induction through nuclear translo-
cation of Nrf2.
3.6. Involvement of PI3K/MAPK pathways in cytoprotection by
kahweol
ZnPP has been used as an HO inhibitor. To determine
whether the increased HO-1 activity induced by kahweol could
confer cytoprotection against oxidative stress, SH-SY5Y cellswere pretreatedwith theHO-1 inhibitor ZnPP. ZnPP attenuated
the protective eﬀect of kahweol on 6-OHDA-induced cytotoxic-
ity (Fig. 6A), suggesting that the cytoprotective eﬀect of kahweol
is partly mediated through HO-1 induction. Moreover, inhibi-
tors of PI3K/Akt and p38 also attenuated the protective eﬀect
of kahweol on 6-OHDA-induced cytotoxicity (Fig. 6B–D), sug-
gesting the involvement of PI3K/Akt and p38 signaling in kah-
weol mediated HO-1 gene induction and cytoprotection.
In conclusion, kahweol induces HO-1 expression in dopami-
nergic SH-SY5Y neuronal cells, and this expression confers
cytoprotection against oxidative injury. Kahweol also induces
Nrf2 nuclear translocation, which is upstream of kahweol-in-
duced HO-1 expression, and activates PI3K/Akt and p38 phos-
phorylation. The PI3K/Akt and p38 pathways are involved in
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